1 |
Creutzberg CL, van Putten WLJ, Koper PC, et al. The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial. Int J Radiat Oncol Biol Phys 2001;51:1246-1255
DOI
ScienceOn
|
2 |
Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium: Results of 550 patients with pathologic stage I disease. Gynecol Oncol 1998;70:247-254
DOI
ScienceOn
|
3 |
Creasman WT, Morrow C, Bundy B, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987; 60:2035-2041
DOI
ScienceOn
|
4 |
Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I & II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65
DOI
ScienceOn
|
5 |
Grigsby PW, Perez CA, Kutten A. Clinical stage I endometrial cancer; prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys 1992;22:905-911
DOI
PUBMED
ScienceOn
|
6 |
Kadar N, Malfetano JH, HOmesley HD. Determinats of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy. Obstet Gynecol 1992;80:655-659
PUBMED
|
7 |
Kucera H, Vavra N, Weghaupt K. Benefit external irradiation in pathologic stage I endometrial carcinoma; a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavarable prognostic factors. Gynecol Oncol 1990;38:99-104
DOI
ScienceOn
|
8 |
Fanning J. Long-term survival of intermediate risk endometrial cancer (Stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 2001;82:371-374
DOI
ScienceOn
|
9 |
Editorial. GOG99: Ending the controversy regarding pelvic radiotherapy for endometrial cancer. Gynecol Oncol 2004;92:740-743
DOI
ScienceOn
|
10 |
Weiss E, Hirnle P, Arnold-Botinger H, Hess CF, Bamberg M. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy. Gynecol Oncol 1998;71:172-176
DOI
ScienceOn
|
11 |
Hamilton CA, Liou WS, Osann K, et al. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2005;63:839-844
DOI
ScienceOn
|
12 |
Lanciano RM, Com BW, Schultz DJ, Kramer CA, Rosenblum N, Hogan WM. The justification for a surgical staging system in endometrial carcinoma. Radiother Oncol 1993;28:189-196
DOI
ScienceOn
|
13 |
Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. Post Operative Radiation Therapy in Endometrial Carcinoma. (PORTEC) Study Group. Lancet 2000;355:1404-1411
DOI
ScienceOn
|
14 |
Roberts JA, Brcenetto VL, Keys HM, et al. A phase III randomized study of surgery vs surgery plus adjunctive radiation therapy in intermediate-risk endometrial carcinoma. Gynecol Oncol 1998;68:135
|
15 |
Nelson G, Randall M, Sutton G, et al. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes. analysis of treatment outcomes, prognostic variables and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999;75:211-214
DOI
ScienceOn
|
16 |
Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage I endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys Biol 2005;63:834-838
DOI
ScienceOn
|
17 |
PORTEC-2: Postoperative radiation therapy for endometrial carcinoma: a multicentric randomized phase III trial comparing external beam radiation and vaginal brachytherapy: Nederlands Trial Register http//www.trialreigster.nl/trialreg/admin/retview.asp? TC=332 Accessed September 9, 2005
|
18 |
Alektiar KM, Venkatraman E, Baraket RR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005;62:111-117
DOI
ScienceOn
|
19 |
International Federation of Gynecology and Obstetrics. Annual report on the results of Treatment in gynecologic cancer. Int J Genecol Obstet 1989;28:189-190
DOI
ScienceOn
|
20 |
Greven KM, Corn B, Lanciano RM, Case D, Randall ME. Pathologic stage III endometrial carcinoma: Pathologic stage III endometrial carcinoma: significance of extrauterine sites. Radiat Oncol Invest 1996;4:122-128
DOI
ScienceOn
|
21 |
Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate-risk endometrial adenocarcioma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-751 [Erratum in Gynecol Oncol 2004;94:241-242]
DOI
ScienceOn
|
22 |
Mayr NA, Wen BC, Benda JA, et al. Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement-Patterns of failure. Radiology 1995;196: 323-328
DOI
PUBMED
|
23 |
Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 2007;106:215-220
DOI
ScienceOn
|
24 |
Lin LL, Mutch DG, Rader JS, Powel MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate-risk endometrial cancer. Gynecol Oncol 2007;196:215-220
|
25 |
Sutton G, Axelrod JH, Bundy BN, et al. Adjuvant whole abdominal irradiation in clinical stage I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2006;100:349-354
DOI
ScienceOn
|
26 |
Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006;295:389-397
DOI
ScienceOn
|
27 |
Greven KM, Corn BW. Endometrial cancer. Curr Probl Cancer 1997;21:65-127
DOI
ScienceOn
|
28 |
Inoue Y, Obata K, Abe K, et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 1996;78:1447-1451
DOI
ScienceOn
|
29 |
Webb GA, Lagos MD. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 1987;156:1486-1491
DOI
PUBMED
|
30 |
Kang MK, Huh SJ, Park W, et al. The results of postoperative radiotherapy for early sage endometrial carcinoma. J Korean Soc Ther Radiol Oncol 2006;24:116-122
과학기술학회마을
|
31 |
Alektiar KM, Venkatramen E, Barakat RR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2005;62:111-117
DOI
ScienceOn
|
32 |
Ny TY, Perrin LO, Nicklin JL, Cheuk R, Crandon AJ. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 2000;79:490-494
DOI
ScienceOn
|
33 |
Creutzberg CL, van Putten WLJ, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clinical Oncology 2004;22;123-1241
|
34 |
Nunns D, Williamson K, Swancy L, Davy M. The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer 2000;10:233-238
DOI
ScienceOn
|
35 |
2002 Annual Report of the Korea Central Cancer Registry
|
36 |
Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-427
PUBMED
|
37 |
Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma. a highly malignant form of endometrial adenocarcinoma. Am J Surg Path 1982;6:93-108
DOI
ScienceOn
|
38 |
Greven KM, Lanciano RM, Herbert SH, Hogan PE. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation. Int J Radiat Oncol Biol Phys 1991;21:919-923
DOI
ScienceOn
|
39 |
Lim P, Al Kushi A, Gilks B, Wong F, Aquino-Parsons C. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome. Cancer 2001;91:752-757
DOI
ScienceOn
|
40 |
Grigsby EW, Perez CA, Kuske RR, Kao MS, Galakatos AE. Results of therapy analysis of failures and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium. Gynecol Oncol 1987;27:44-57
DOI
ScienceOn
|
41 |
Jolly S, Vargus C, Kumar T, et al. Vaginal brachytherapy alone; an alternative to adjuvant whole pelvic radiation for early stage endometrial cancer. Gynecol Oncol 2005;97:887-892
DOI
ScienceOn
|
42 |
Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys 1990;19:49-54
DOI
ScienceOn
|
43 |
Corn BW, Lanciano RM, Greven KM, et al. Impact of improved irradiation technique, age and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol 1994;12:510-515
DOI
|
44 |
NCCN Clinical Guidelines in Oncology. Uterine cancer V.2. 2008. National Comprehensive Cancer Network. www.nccn.org
|
45 |
Potish RA, Twiggo LB, Adcock LL, et al. Para-aortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985;654:251
|
46 |
Descamp P, Calais G, Moire C, et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997;64:54-58
DOI
ScienceOn
|
47 |
Petereit DG, Tannehil SP, Grosen EA, Hartenbach EM, Schink JC. Outpatient vaginal cuff brachytherapy for endomtrial cancer. Int J Radiat Oncol Biol Phys 1999;9:456-462
|
48 |
Chada M, Nanavati PJ, Lia P, Fanning J, Macobs A. Pattern of failure in endometrial carcioma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 1999;75:103-107
DOI
ScienceOn
|
49 |
Horowitz NS, Peters WA, Smith MR, Drescher CW, Atwood M, Mate TP. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol 2002;99:235-240
DOI
ScienceOn
|
50 |
Aalders J, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium; a clinical and histopathological study of 379 patients. Gynecol Oncol 1984;17:85
DOI
ScienceOn
|